A recent clinical study has found that compound lidocaine cream delivers superior pain relief during facial rejuvenation procedures compared to standard lidocaine–prilocaine formulations. The findings highlight improved patient comfort, lower pain scores, and strong safety performance across multiple cosmetic dermatology techniques.
Randomised controlled trial
Researchers conducted a randomised controlled trial involving 100 participants undergoing facial aesthetic procedures. The study compared two groups, one receiving compound lidocaine cream and the other receiving a commonly used lidocaine–prilocaine cream. Patients were assessed using a standardised visual analogue scale to measure pain intensity during treatment.
Lower pain scores
The results showed a clear reduction in pain among patients using compound lidocaine cream. The average pain score in this group was significantly lower than the comparator group. Patients also reported higher satisfaction levels during and after procedures, suggesting a better overall treatment experience.
Consistent performance
Clinicians used multiple facial rejuvenation techniques in the trial, including hydro-injection, microneedling, and fractional laser therapy. Across all procedures, the compound lidocaine formulation consistently demonstrated stronger analgesic effects. This consistency strengthened the reliability of the findings across different aesthetic applications.
Safety outcomes
Safety outcomes also supported the use of compound lidocaine cream. Adverse effects were low in both groups, with only minor differences observed. Researchers noted that side effects occurred less frequently in the compound lidocaine group, although the difference was not statistically significant.
The study also highlighted improved patient compliance. Patients who experienced less pain were more likely to complete recommended aesthetic treatment sessions. This suggests that better anaesthesia may indirectly improve clinical outcomes in cosmetic dermatology.
Despite the positive results, researchers advised caution in interpreting the findings. They noted that differences in total anaesthetic concentration between formulations could influence outcomes. They also emphasised the need for larger studies to confirm long-term safety and true formulation superiority.
Importance of pain management
Experts involved in the study concluded that effective topical anaesthesia plays a critical role in aesthetic medicine. Pain control significantly influences patient satisfaction and willingness to undergo repeat procedures. Improved formulations like compound lidocaine cream may therefore enhance both clinical efficiency and patient experience.
The study was published in the Journal of Cosmetic Dermatology. It contributes to growing evidence supporting advanced topical anaesthetic formulations in dermatological procedures.
Researchers recommend further investigation with larger and more diverse populations. They also suggest evaluating cost-effectiveness and optimal dosing strategies. These steps could help determine how best to integrate compound lidocaine cream into routine clinical practice.
Improved patient comfort and safety
Overall, the findings suggest that compound lidocaine cream may represent a meaningful advancement in pain management for facial rejuvenation procedures. It shows promise in improving comfort without compromising safety.